Drugs / PEG-ELS
PEG-ELS
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase not applicable2 trials | ||||||
| — | NCT01665157 | Nov 2011 → Jun 2012 | — | National Taiwan University Hospital | Completed | Mixed |
| — | NCT01028573 | Nov 2009 → Jul 2012 | — | Southern California Institute for Research and Education | Unknown | No outcome recorded |
| Comparator or background therapy4 trials | ||||||
| Phase 3 | NCT02819323 Comparator | Jun 2016 → Mar 2018 | — | Braintree Laboratories | Completed | No outcome recorded |
| Phase 3 | NCT01356407 Comparator | Jan → May 2011 | — | Ferring Pharmaceuticals | Completed | No outcome recorded |
| Phase 4 | NCT02761317 Comparator | May → Nov 2016 | — | Shandong University | Unknown | No outcome recorded |
| — | NCT01299779 Comparator | Jun 2010 → May 2012 | — | Thomas Jefferson University | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PEG-ELS | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02761317 ↗ |
| Known as | Golytely | “4L of PEG-ELS (Golytely) consumed on the evening before colonoscopy” NCT01028573 ↗ |
| Known as | Polyethylene Glycol-electrolyte 4000 Powder for Oral Solution | “Polyethylene Glycol-electrolyte 4000 Powder for Oral Solution (PEG-ELS)” NCT01356407 ↗ |
| Route | Oral | “4L of PEG-ELS (Golytely) consumed on the evening before colonoscopy” NCT01028573 ↗ |